PSMA (prostate specific membrane antigen) shows promise as a general cancer marker in addition to prostate cancer
This article was originally published in Clinica
Executive Summary
Prostate specific membrane antigen (PSMA) can act as a diagnostic for a wide variety of cancers in addition to prostate cancer, researchers at the Memorial Sloan-Kettering Cancer Center in Princeton, New Jersey have confirmed. However, unlike prostate cancer where it occurs in tumour cells, in these cancers PSMA appears to be associated with the growth of new blood vessels in malignant tissue, lead researcher Dr Sam Chang reports in Cancer Research (July).